HSA also binds and transports NEFAs at several sites [28,29,30] and, importantly, pathophysiological concentrations of these fatty acids (as documented in obesity and T2DM) perturb the ability of HSA to bind and buffer Zn2+ [31]. The gene discussed is ALB; the disease is type 2 diabetes mellitus.